Forebright Capital
光远投资
elsewhere's corpus does not cover Forebright Capital as a subject in its own right. The available references only mention it in passing as a co-investor or lead investor in deals reported by partner institutions: it led the Series A in digital food-tech company BOTINKIT (不停科技) in July 2023 , participated in MedSci Healthcare's nearly 2 billion yuan Series E1 in late 2020 , and continued to back physical-AI firm DeepWise in its Series B in mid-2026 . These citations do not provide Forebright's founding date, team, assets under management, or investment strategy.
AI-generated — may contain errors, please verify.
Coverage
Source Code Capital | Physical AI Firm DeepWise Closes Hundreds of Millions of RMB in Series B Funding, Existing Shareholder Source Code Capital Increases Stake
Source Code Capital led J&T Global Express's Pre-A round in 2022, and continued to increase its investment in multiple subsequent rounds, providing long-term support as the company grew.
Heart Capital AI Portfolio Company Shanji Technology Raises Tens of Millions of Yuan in Series A Funding, to Launch China's First Mass-Produced AI Camera Glasses | HeartStar PORTFOLIO
Continuously tracking global investment opportunities in artificial intelligence and digitalization.
August: Keep Pushing Forward | 5Y News Monthly
The big news from last month.
5Y News | Digital Food Tech Company BOTINKIT Raises Tens of Millions of Dollars in Series A Funding
Exploring the global market for food robots and AI.
5Y News | MedSci Healthcare Announces Nearly 2 Billion Yuan Series E1 Funding Round
5Y Capital will continue to focus on how technological innovation drives efficiency gains and paradigm shifts in China's healthcare services sector.
